These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness. Basnyat B, Gertsch JH, Holck PC. High Alt Med Biol; 2008; 9(4):349; author reply 351-2. PubMed ID: 19115924 [No Abstract] [Full Text] [Related]
5. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide. Bärtsch P, Schneider M. BMJ; 2001 Jan 06; 322(7277):48-9. PubMed ID: 11141168 [No Abstract] [Full Text] [Related]
6. Medication Use Among Mount Everest Climbers: Practice and Attitudes. Luks AM, Grissom C, Freer L, Hackett P. High Alt Med Biol; 2016 Dec 06; 17(4):315-322. PubMed ID: 27763796 [Abstract] [Full Text] [Related]
10. Are we doing our best to educate travelers about the risks of acute mountain sickness? An on-site prospective study in the Himalayas. Paz A, Steinfeld I, Potasman I. J Travel Med; 2007 Dec 06; 14(3):168-72. PubMed ID: 17437472 [Abstract] [Full Text] [Related]
11. Prophylaxis of acute mountain sickness. Ramsay LE. Lancet; 1977 Mar 05; 1(8010):540-1. PubMed ID: 65630 [No Abstract] [Full Text] [Related]
12. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Basnyat B, Holck PS, Pun M, Halverson S, Szawarski P, Gertsch J, Steif M, Powell S, Khanal S, Joshi A, Shankar R, Karambay J, Alexander HD, Stone A, Morrissey C, Thompson BH, Farrar J, SPACE Trial Group. Wilderness Environ Med; 2011 Mar 05; 22(1):15-22. PubMed ID: 21377114 [Abstract] [Full Text] [Related]
17. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. Kayser B, Hulsebosch R, Bosch F. High Alt Med Biol; 2008 Nov 01; 9(1):15-23. PubMed ID: 18331216 [Abstract] [Full Text] [Related]
18. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP. BMJ; 2012 Oct 18; 345():e6779. PubMed ID: 23081689 [Abstract] [Full Text] [Related]
19. Prevention of acute mountain sickness in Nepali porters: a controlled trial. Ghimire LV, Pun M. Wilderness Environ Med; 2007 Oct 18; 18(1):72-3; author reply 73-4. PubMed ID: 17447720 [No Abstract] [Full Text] [Related]
20. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Gertsch JH, Lipman GS, Holck PS, Merritt A, Mulcahy A, Fisher RS, Basnyat B, Allison E, Hanzelka K, Hazan A, Meyers Z, Odegaard J, Pook B, Thompson M, Slomovic B, Wahlberg H, Wilshaw V, Weiss EA, Zafren K. Wilderness Environ Med; 2010 Sep 18; 21(3):236-43. PubMed ID: 20832701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]